文献速递其他结缔组织病

系统性硬化症皮肤是为软组织钙化预置的微环境:一个假说

Systemic sclerosis skin is a primed microenvironment for soft tissue calcification-a hypothesis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本文提出假说:系统性硬化症(SSc)皮肤细胞外基质(ECM)的改变,包括微纤维网络破坏和I型胶原积聚,反映细胞表型变化并形成促进软组织钙化的预置微环境,SSc成纤维细胞获得促骨生成表型,特定驱动力促进组织矿化。

要点

  • SSc相关钙化症影响20-40%患者,发病机制不明且无有效改善病情药物。
  • SSc皮肤ECM改变包括微纤维网络破坏和I型胶原积聚。
  • 假说认为SSc成纤维细胞促骨生成表型与ECM改变共同预置钙化微环境。

核心结论

  • SSc皮肤病理改变反映细胞表型变化,形成促进软组织钙化的预置微环境。

研究设计与样本

  • 本文为假说性文章,基于对SSc皮肤细胞外基质改变的分析提出机制假说。

主要发现

  • 钙化症影响20-40%的SSc患者,与疾病病程、指端缺血和肢端骨质溶解相关。
  • SSc皮肤ECM显著改变,包括微纤维网络破坏和I型胶原积聚。
  • SSc成纤维细胞获得促骨生成表型,特定驱动力促进组织矿化。

临床怎么用

  • 考虑ECM在疾病进展中的作用可能有助于阐明SSc相关钙化机制并指导未来治疗干预开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Calcinosis cutis, defined as sub-epidermal deposition of calcium salts, is a major clinical problem in patients with SSc, affecting 20-40% of patients. A number of recognized factors associated with calcinosis have been identified, including disease duration, digital ischaemia and acro-osteolysis. Yet, to date, the pathogenesis of SSc-related calcinosis remains unknown, and currently there is no effective disease-modifying pharmacotherapy. Following onset of SSc, there are marked changes in the extracellular matrix (ECM) of the skin, notably a breakdown in the microfibrillar network and accumulation of type I collagen. Our hypothesis is that these pathological changes reflect a changing cellular phenotype and result in a primed microenvironment for soft tissue calcification, with SSc fibroblasts adopting a pro-osteogenic profile, and specific driving forces promoting tissue mineralization. Considering the role of the ECM in disease progression may help elucidate the mechanism(s) behind SSc-related calcinosis and inform the development of future therapeutic interventions.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Burgess KA, Herrick AL, Watson REB, et al. Systemic sclerosis skin is a primed microenvironment for soft tissue calcification-a hypothesis. Rheumatology (Oxford). 2021. PMID: 33585894. doi:10.1093/rheumatology/keab156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。